Children with Congenital Heart Disease Are Active but Need to Keep Moving: A Cross-Sectional Study Using Wrist-Worn Physical Activity Trackers.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
02 2020
Historique:
received: 08 07 2019
revised: 12 08 2019
accepted: 27 09 2019
pubmed: 20 11 2019
medline: 28 7 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

To compare daily physical activity of children with congenital heart disease (CHD) with healthy peers measured using wearables bracelets in a large cohort. Additionally, subjectively estimated and objectively measured physical activity was compared. From September 2017 to May 2019, 162 children (11.8 ± 3.2 years; 60 girls) with various CHD participated in a self-estimated and wearable-based physical activity assessment. Step-count and moderate-to-vigorous physical activity were recorded with the Garmin vivofit jr. for 7 consecutive days and compared with a reference cohort (RC) of 96 healthy children (10.9 ± 3.8 years; 49 girls). Children with CHD were active and 123 (75.9%) achieved 60 minutes physical activity on a weekly average according to the World Health Organization criteria as 81 (84.3%) of the healthy peers did (P = .217). After correction for age, sex, and seasonal effects, only slightly lower step count (CHD: 10 206 ± 3178 steps vs RC: 11 142 ± 3136 steps; P = .040) but no lower moderate-to-vigorous physical activity (CHD: 80.5 ± 25.6 minutes/day vs RC: 81.5 ± 25.3 minutes/day; P = .767) occurred comparing CHD with RC. In children with CHD higher age (P = .004), overweight or obesity (P = .016), complex severity (P = .046), and total cavopulmonary connection (P = .027) were associated with not meeting World Health Organization criteria. Subjective estimation of daily moderate-to-vigorous physical activity was fairly correct in half of all children with CHD. Even though the majority is sufficiently active, physical activity needs to be promoted in overweight or obese patients, patients with complex CHD severity, and in particular in those with total cavopulmonary connection.

Identifiants

pubmed: 31740142
pii: S0022-3476(19)31314-9
doi: 10.1016/j.jpeds.2019.09.077
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-19

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Leon Brudy (L)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany; Institute of Preventive Pediatrics, Technical University Munich, Munich, Germany. Electronic address: leon.brudy@tum.de.

Julia Hock (J)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany.

Anna-Luisa Häcker (AL)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany; Institute of Preventive Pediatrics, Technical University Munich, Munich, Germany.

Michael Meyer (M)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany; Institute of Preventive Pediatrics, Technical University Munich, Munich, Germany.

Renate Oberhoffer (R)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany; Institute of Preventive Pediatrics, Technical University Munich, Munich, Germany.

Alfred Hager (A)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany.

Peter Ewert (P)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany.

Jan Müller (J)

Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Munich, Germany; Institute of Preventive Pediatrics, Technical University Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH